[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60469-60470]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-23864]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-15-0919]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

[[Page 60470]]

Proposed Project

    Generic Clearance for the Collection of Qualitative Feedback on 
Agency Service Delivery (OMB No. 0920-0919, expires 01/31/2015)--
Revision--National Center on Birth Defects and Developmental 
Disabilities (NCBDDD), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    As part of a Federal Government-wide effort to streamline the 
process to seek feedback from the public on service delivery, the CDC 
has submitted a Generic Information Collection Request (Generic ICR): 
``Generic Clearance for the Collection of Qualitative Feedback on 
Agency Service Delivery '' to OMB for approval under the Paperwork 
Reduction Act (PRA) (44 U.S.C. 3501 et. seq.).
    To request additional information, please contact LeRoy A. 
Richardson, Reports Clearance Officer, Centers for Disease Control and 
Prevention, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an 
email to [email protected].
    Supplementary Information:
    Title: Generic Clearance for the Collection of Qualitative Feedback 
on Agency Service Delivery.
    Abstract: The information collection activity will garner 
qualitative customer and stakeholder feedback in an efficient, timely 
manner, in accordance with the Administration's commitment to improving 
service delivery. By qualitative feedback we mean information that 
provides useful insights on perceptions and opinions, but are not 
statistical surveys that yield quantitative results that can be 
generalized to the population of study. This feedback will provide 
insights into customer or stakeholder perceptions, experiences and 
expectations, provide an early warning of issues with service, or focus 
attention on areas where communication, training or changes in 
operations might improve delivery of products or services. These 
collections will allow for ongoing, collaborative and actionable 
communications between the Agency and its customers and stakeholders. 
It will also allow feedback to contribute directly to the improvement 
of program management.
    Feedback collected under this generic clearance will provide useful 
information, but it will not yield data that can be generalized to the 
overall population. This type of generic clearance for qualitative 
information will not be used for quantitative information collections 
that are designed to yield reliably actionable results, such as 
monitoring trends over time or documenting program performance. Such 
data uses require more rigorous designs that address: The target 
population to which generalizations will be made, the sampling frame, 
the sample design (including stratification and clustering), the 
precision requirements or power calculations that justify the proposed 
sample size, the expected response rate, methods for assessing 
potential non-response bias, the protocols for data collection, and any 
testing procedures that were or will be undertaken prior fielding the 
study. Depending on the degree of influence the results are likely to 
have, such collections may still be eligible for submission for other 
generic mechanisms that are designed to yield quantitative results.
    This is a revision to a previously approved collection of 
information. Respondents will be screened and selected from Individuals 
and Households, Businesses Organizations, and/or State, Local or Tribal 
Government. A total of 12 individual data collections were approved 
under our originally approved generic information collection (OMB # 
0920-0919, expiration 01/31/2015). Data collection activities were 
equally divided between focus groups and online surveys and were 
conducted to test and refine NCBDDD messages and materials regarding 
alcohol use during pregnancy, autism spectrum disorder, folic acid, 
Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE), and preconception 
health. A customer service survey was also conducted using this 
mechanism.
    We expect to conduct 12 individual data collections (four each 
year) over the next three years in order to continue testing and 
refining our public health messages aimed at targeted groups by using a 
variety of instruments and platforms. Based on the number of burden 
hours actually used during the initial approval period and the number 
of respondents involved, we request a reduction in the number of 
respondents and burden hours.
    Below we provide CDC's projected annualized estimate for the next 
three years. There is no cost to respondents other than their time. The 
estimated annualized burden hours for this data collection activity are 
3,625.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Annual
          Type of respondent                    Form name            Number of     frequency per     Hours per
                                                                    respondents      response        response
----------------------------------------------------------------------------------------------------------------
General Public/Public Health            Online surveys..........           2,500               1           30/60
 Practitioners/Delivery Partners and
 Stakeholders.
General Public/Public Health            Paper surveys...........             750               1           30/60
 Practitioners/Delivery Partners and
 Stakeholders.
General Public/Public Health            Focus groups............           1,000               1               2
 Practitioners/Delivery Partners and
 Stakeholders.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-23864 Filed 10-6-14; 8:45 am]
BILLING CODE 4163-18-P